Ibis Reproductive Health

This supplemental grant is for Ibis’ expanded programmatic work to meet the recent challenges in the reproductive health, rights, and justice landscape in the United States. In order to help Ibis meet the moment, U.S. Reproductive Equity is providing this additional funding. Ibis Reproductive Health improves women’s reproductive autonomy, choices, and health by conducting research and pursuing principled partnerships in the United States, Latin America, and sub-Saharan Africa to inform advocacy for access to safe, affordable, high-quality reproductive health care. Ibis works to increase access to high-quality abortion services, transform access to abortion and contraception through technology and service innovations, and expand comprehensive sexual and reproductive health information and services. This grant is aligned with both the Global and U.S. Reproductive Equity strategies.

Ibis Reproductive Health improves women’s reproductive autonomy, choices, and health by conducting research and pursuing principled partnerships in the United States, Latin America, and sub-Saharan Africa to inform advocacy for access to safe, affordable, high-quality reproductive health care. Ibis works to increase access to high-quality abortion services, transform access to abortion and contraception through technology and service innovations, and expand comprehensive sexual and reproductive health information and services. This grant is aligned with both the Global and U.S. Reproductive Equity strategies.

Ibis Reproductive Health improves women’s reproductive autonomy, choices, and health by conducting research in the United States, Latin America, and sub-Saharan Africa to inform advocacy for access to safe, affordable, high-quality reproductive health care. During this grant period, Ibis’ efforts will include a focus on testing new approaches to measure the quality of abortion services and abortion stigma, building new partnerships with service delivery and advocacy groups that can best identify their communities’ research needs, and managing the effort to make an oral contraceptive available over-the-counter in the United States.